Why aren't we figuring out how to cure the test bottleneck?
Plus, why shares of vaccine maker Moderna are taking a hit.
Monday's rally might have been ugly, except that this is 2020. Anything goes in 2020.
The market seems to be overlooking this trio of potential setbacks to stocks.
Concerns over the strength of the recovery in the jobs market and the rate of Covid-19 cases are reasons for caution despite a resurgent market.
The Fed, as much as it would like, cannot print a vaccine nor change human psychology.
While every recession is different, here's what could be in store for jobs, interest rates, the Fed and stocks.
What if the market is simply pricing in a quarter that had already been priced out?
The central bank is stuck between a rock and a hard place, which it knows fully well.
It is tough for the bears to gain traction with their macro arguments, when dip buyers and aggressive pockets of trading action remain -- so continue to look to price action for guidance.